Sandy Wong



About me

Dr. Sandy Wong is a blood disease specialist who cares for people with MGUS (monoclonal gammopathy of undetermined significance), smoldering myeloma, multiple myeloma and amyloidosis, a condition in which an abnormal protein called amyloid builds up in the body.

Wong has a special interest in amyloidosis patients, and her research focuses on that disease. She studies patients with AL amyloidosis (the most common type) whose kidneys are affected, as well as those with chromosomal abnormalities. She also is designing a clinical trial for a promising new drug to treat multiple myeloma.

After graduating from Brown University with a degree in human biology, Wong earned her medical degree at the University of Massachusetts. She then completed an internal medicine residency followed by a hematology-oncology fellowship at Tufts Medical Center.

Wong is a member of the American Society of Hematology and American Society of Clinical Oncology.

  • Education

    University of Massachusetts, 2009

  • Residencies

    Tufts Medical Center, Internal Medicine, 2012

  • Fellowships

    Tufts Medical Center, Hematology-Oncology, 2016

  • Board Certifications

    Internal Medicine, American Board of Internal Medicine

  • Academic Title

    Assistant Professor

  • Languages



Hematology and Blood and Marrow Transplant

400 Parnassus Ave., Fourth Floor
San Francisco, CA 94143

My reviews


Overall Experience
168 Reviews
Dr. Wong is the best. She is personable and really focuses on me with the time allowed. She is always willing to explain my care with me so I can understand. Thank you Dr. Wong.
Explained things in a way that was easy to understand
167 Reviews
Did the doctor pay attention to your concerns
168 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
163 Reviews
Knew the important information about your medical history
167 Reviews
The provider showed respect for what you had to say
168 Reviews
The provider spent enough time with me
168 Reviews
Decorative Caduceus

Study Evaluating the Safety and Efficacy of JCARH125 in Subjects With Relapsed and/or Refractor...

Proportion of subjects with adverse events meeting DLT criteria


Decorative Caduceus

Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Subjects With Relapsed and Refract...

Number of participants with Adverse Events


Decorative Caduceus

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Number of patients with treatment-related adverse events as assessed by NCI CTCAE v5.0.